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&p.1:Abstract Expression of epithelial cytokeratins type 8, 18
and 19 can be used to study smooth muscle cell differen-
tiation during development. We studied the differentiation
of smooth muscle cells in the ductus arteriosus before and
during intimal thickening and compared the changes oc-
curring in this vessel with the adjoining elastic ascending
and descending aorta and the pulmonary trunk. The duc-
tus arteriosus, a vessel connecting the pulmonary trunk
and the aorta during fetal life, constricts shorty after birth
and eventually closes. Effective closure occurs only in the
case of well developed intimal thickening. Cytokeratin
expression during fetal development was greatest in the
media of the ascending aorta and pulmonary artery, while
in the ductus and descending aorta cytokeratin staining
was slight. These results suggest that ductus smooth mus-
cle cells and the smooth muscle cells of the descending
aorta show a more advanced differentiation as compared
to the ascending aorta and pulmonary artery. At neonatal
stages cytokeratin expression in the descending aorta,
pulmonary artery and the ascending aorta had disap-
peared as was expected with increased differentiation. In
the neonatal ductus arteriosus reexpression of cytokera-
tins was found in cell clusters in the hyaluronic acid rich
environment of the intimal thickening and in the inner
media. Reexpression of cytokeratins, especially when or-
ganized in clusters, may reflect changes in gene regula-
tion. Therefore the clusters of cytokeratin positive cells in
the ductus may be indicative of extensive changes, occur-
ring during closure of this vessel in the neonatal period,
in which inner media and intima are especially involved.&bdy:
Introduction
Differentiation of vascular smooth muscle cells (SMC)
can be characterized by the up and down regulation of
several structural proteins. The amount of contractile
proteins increases as the SMC become more differentiat-
ed [13], whereas the expression of several splice variants
of fibronectin [14] and cytokeratins [15] is reported to
decrease during development. Cytokeratins are an inter-
mediate filament protein family, normally expressed in
epithelial cells and epithelial neoplastic tissues [24]. Ex-
pression of the cytokeratins of the simple epithelium
type is not restricted to epithelial cells, however, and
these cytokeratins are also found in certain cells of mes-
enchymal origin [36, 37]. For example cytokeratins 8, 18
and 19 have been reported in a number of SMC tumors
[4, 16, 26, 31], in vascular SMC during fetal develop-
ment [15, 36] and in pathologic intimal thickening [15,
17, 18]. In vascular SMC cytokeratins 8, 18 and 19 are
associated with the undifferentiated phenotype during
development [15] and the dedifferentiated phenotype in
pathologic intimal thickening [18]. In certain SMC it is
remarkable that both desmin and vimentin can be co-ex-
pressed with the cytokeratins [1], whereas a hyaluronic
acid rich environment [19] also seems to be favoured.
The latter is a typical phenomenon for the neonatal DA
[8, 34].
In the present study we have examined the expression
of cytokeratins 8, 18 and 19 in the human arterial great
vessels and focused on the ductus arteriosus (DA) as this
vessel has an advanced stage of differentiation of the
contractile apparatus during fetal development as com-
pared to the ascending and descending aorta and pulmo-
nary trunk [20, 35]. The DA is muscular artery connect-
ing the aorta and pulmonary trunk during fetal life. The
closure of this vessel shortly after birth is preceded dur-
ing fetal gestation by the formation of intimal thickening
that is essential for effective closure [9]. This physiologi-
cal intimal thickening resembles the intimal thickening
found in arteriosclerosis [8, 34]. In this way cytokeratin
expression can be linked to the various stages of SMC
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differentiation that are present in the DA and adjoining
great vessels during development, including the forma-
tion of intimal thickening.
Methods
Tissue samples
Fetal DA, aorta and pulmonary trunk were obtained from five human
fetuses between 13 and 19 weeks of amenorrhea. Two DA did not
show signs of intimal thickening (13–15 weeks gestation) and three
DA were showing intimal changes (17–19 weeks). The fetuses stud-
ied did not show any macroscopically detectable abnormalities. Five
normal neonatal DA were resection specimens of the middle part of
the DA obtained during cardiac surgery from children between 1 and
3 weeks of age. These children had been treated with prostaglandin
E1 to maintain ductal patency. Previous studies have shown that de-
spite the various cardiac malformations the DA of these patients is
normal with respect to functional and morphological characteristics
[10, 22, 34]. Aortic and pulmonary vessel wall of three similarly
treated patients between 1 and 3 weeks of age were used as well as
an aorta from a 21-month-old child. Specimens were obtained with
approval of the Institutional Review Board of the Dijkzigt University
Hospital, the Netherlands. All specimens were rinsed in phosphate
buffered saline (PBS) containing 6.8% sucrose and were submerged
in OCT compound (Tissue Tek, Miles Laboratories, Naperville,
USA). Specimens were quickly frozen in liquid-nitrogen-chilled iso-
pentane and stored at 20° C. Sections (5 µm thick) were cut at −12°
C and stored at −20° C until immunohistochemistry was performed.
To study the morphology of the arteries we used hematoxylin-eosin
(HE) and resorcin-fuchsin (RF) staining.
Monoclonal antibodies
For the detection of cytokeratins 8, 18 and 19 several monoclonal
antibodies were used. The monoclonal antibodies CAM 5.2 [23]
and M2O [32, 36] are specific for cytokeratin 8. RGE 53 [29] and
RCK 106 [30] recognized cytokeratin 18 and RCK 108 [33] recog-
nized cytokeratin 19.
Immunohistochemistry
Both the immunofluorescence and the immunoperoxidase method
were used. Immediately before use the sections were fixed in cold
methanol (−20° C), followed by a 1-min acetone fixation at room
temperature and were air dried for 1 h. The sections were hydrated
and rinsed in PBS. For the immunoperoxidase method endogenous
peroxidase activity was removed by 15 min of incubation in PBS
containing 0.3% H2O2.
The primary antibody was diluted 1:5 in PBS containing 0.1%
bovine serum albumin and 0.05% Tween-20. After an overnight
incubation in a moist chamber, three washing steps in PBS were
performed. For the immunofluorescent detection method we incu-
bated the sections with a TRITC-conjugated rabbit antibody to
mouse immunoglobulin (1:50, DAKO A/S, Glostrup, Denmark),
washed three times in PBS and mounted in a mixture of 80% glyc-
erol and 20% PBS, pH 8.0, containing 1 mg/ml p-phenylenedia-
mide as anti-fading reagent. For the peroxidase method we used a
horseradish peroxidase conjugated rabbit antibody to mouse im-
munoglobulin (1:300, DAKO A/S) as a secondary antibody. After
three washing steps in PBS, the sections were exposed to 0.04%
diaminobenzidine tetrahydrochloride (DAB) in 0.05 M Tris-male-
ate buffer (pH 7.6) with 0.006% H2O2 for 8 min. The reaction was
stopped in PBS and sections were counterstained with hematoxy-
lin. The sections were dehydrated in graded ethanol and mounted
in Entellan (Merck, Darmstadt, FRG).
Immunohistochemical staining results were studied by light
microscopy and scored by at least two independent researchers.
Results
Fetal Arteries
The two fetal DA between 13 and 15 weeks showed no
signs of intimal thickening yet. The three fetal DA be-
tween 17 and 19 weeks displayed fragmentation of the
internal elastic lamina and concomitant lifting of endo-
thelial cells, i.e. the initial signs of intimal thickening
formation. In the ascending and descending aorta and the
pulmonary trunk no intimal thickening was observed.
The ascending aorta (Fig. 1A, C) and pulmonary
trunk (Fig. 1D) of young fetuses between 13 and 15
weeks showed strong expression of cytokeratins 8, 18
and 19. Expression of cytokeratins in the DA (Fig. 1B)
and the descending aorta was weak or even absent. In fe-
tuses between 17 and 19 weeks, the expression in the as-
cending aorta was slightly diminished (Fig. 1E), whereas
cytokeratin expression in the pulmonary trunk had de-
creased (Fig. 1F) to become weaker than the expression
in the ascending aorta. Cytokeratin 8 expression in the
DA showed a slight increase, while cytokeratin 18 and
19 expression had remained similar to the younger stag-
es. Results are summarized in Table 1.
Neonatal arteries
The neonatal DA showed well developed intimal thick-
ening. Two of the DA studied had areas of cytolytic ne-
crosis in the media. Cytolytic necrosis is characterized
by loss of nuclei without an inflammatory respone [9,
11]. The aorta and pulmonary trunk specimens that were
studied showed no signs of intimal thickening.
Neither the neonatal ascending aorta, and pulmonary
trunk, nor the ascending aorta and pulmonary trunk from
a 21-month-old child, showed any expression of cytoker-
atin 8 (Fig. 2D), 18 or 19. Results for the descending
aorta are described by Glukhova and colleagues [15] and
correspond with our data on the ascending aorta and pul-
monary artery. The neonatal DA did express cytokeratins
8, 18 and 19. There was, however, a variation in expres-
sion between the various DA studied. Expression of
cytokeratin 8 was the most pronounced, in some DA al-
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Fig. 1A, B Immunohistochemical staining for cytokeratin 8 of the
ascending aorta (A) and ductus arteriosus (B) of a 13-week-old fe-
tus. Staining of the smooth muscle cells of the ascending aorta is
stronger than of the smooth muscle cells of the ductus, indicating
an advanced differentiation of the smooth muscle cells of the duc-
tus arteriosus. C, D Cytokeratin 8 expression of the ascending aor-
ta (C) and pulmonary artery (D) of a 15-week-old fetus showing
an almost similar staining of the smooth muscle cells. E, F In an
older fetus (18 weeks) the ascending aorta (E) and pulmonary ar-
tery (F) show a difference in that the smooth muscle cells of the
pulmonary artery are now almost negative, indicating advanced
differentiation of these cells as compared to the smooth muscle
cells of the ascending aorta. m media, A and B; bar 50 µm, C–E.
In F, bar 100 µm &/fig.c:
s
308
Table 1 Results of the immunohistochemical cytokeratin staining
reactions in the fetal and neonatal arteries are summarized. The
percentage of positive cells was scored from +++ (all cells) to −
(no cells) using the following catagories: +++>++>+>+/−>+/=>−.
Except for the neonatal DA (see Results) the interindividual vari-
ability of the staining results was low. DA, ductus arteriosus; DAo,
descending aorta; AAo, ascending aorta; PT, pulmonary trunk;
wk, weeks &/tbl.c:&tbl.b:
Antigen Fetal (13–15 wk) Fetal (17–19 wk) Neonatal (1–3 wk) 1.2 year
DA DAo AAo PT DA AAo PT DA AAo PT AAo PT
Cytokeratin 8 +/= +/= +++ +++ + ++ + ++a − − − −
Cytokeratin 18 +/= +/= ++ ++ +/= + +/− +a − − − −
Cytokeratin 19 − − ++ ++ − + +/− +a − − − −
a Staining localized in cell clusters
&/tbl.b:
Fig. 2A–D Neonatal ductus ar-
teriosus stained for cytokeratin
8. A Expression of cytokeratin
8 was found in the intima (i)
and inner media (im), the outer
media being negative. B Higher
magnification of a positive ar-
ea, in which cytokeratin ex-
pression was found in almost
every cell. C Cluster of cyto-
keratin positive cells (arrows)
in the intima in another neona-
tal ductus (C). D The media
(m) of the neonatal ascending
aorta was negative for cytoker-
atin 8; bar 100 µm &/fig.c:
most every SMC was stained except in the outer media
(Fig. 2A, B). Other DA showed clusters of cytokeratin-8-
positive cells located in the intima (Fig. 2C) and inner
media. Expression of cytokeratin 18 (Fig. 3A–C) and 19
(Fig. 3D) was also found in cell clusters. Clusters of
cytokeratin-positive cells were found around areas of
cytolytic necrosis (Fig. 3C) and in areas showing onset
of cytolytic necrosis, but we also encountered randomly
localized clusters of positive cells. No clusters were
found in the outer media. The results are summarized in
Table 1.
Discussion
In this study we have examined the expression of cyto-
keratins 8, 18 and 19 in SMC of the arterial great vessels
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Fig. 3 A Cytokeratin 18 expression was found in cell clusters (ar-
rows) present in all parts of the vessel wall of the ductus arteriosus
except in the outer media. B, C Detail of cytokeratin-positive cell
clusters (arrows) in the intima (i) and inner media (im) (B) and
surrounding the areas with cytolytic necrosis (cn) (C). D Detail of
a cytokeratin-19-positive cluster on the border of the intima and
inner media (im); bar, 100 µm &/fig.c:
during development. In the adult cytokeratins are gener-
ally known as markers of epithelial differentiation and
belong to the family of intermediate filaments [24].
These intermediate filaments consist of six subtypes,
classifying different tissue types. Type I are the small
acidic cytokeratins (9–20) and type II are the large neu-
tral to basic cytokeratins (1–8). The third class, type III
of the intermediate filaments, is formed by the mesen-
chymal protein vimentin, the muscle protein desmin, the
glial fibrillary acidic protein expressed in glial cells and
astrocytes, and peripherin, specific for neuronal cells.
Neurofilaments are type IV, nuclear laminins A and B
type V, and nestin, an intermediate filament specific to
central nervous system stem cells, is type VI. In patho-
logical situations and in tumors, these cell lineage mark-
ers are generally retained, although switches in expres-
sion have been described [24]. Coexpression of two or
three intermediate filaments in one single cell has been
reported. SMC coexpress vimentin, desmin and cyto-
keratins under certain conditions, such as during fetal de-
velopment [36] and SMC oncogenesis [16]. Further-
more, the cytokeratins can be used as markers of SMC
differentiation, as expression of cytokeratins in vascular
SMC is observed during early fetal development, where-
as normal adult SMC do not express cytokeratins [15]. In
a 10-week-old embryo SMC of the descending aorta
contained cytokeratin 8 [15]. In the present study we
found that cytokeratin expression in fetuses between 13
and 15 weeks was very low in the descending aorta and
DA. In contrast the ascending aorta and pulmonary trunk
show a high expression, suggesting that SMC of the DA
and descending aorta are already more differentiated
than those of the pulmonary trunk and the ascending aor-
ta. The special status of the ascending aorta and pulmo-
nary trunk with regard to SMC differentiation has also
been described on the basis of actin expression [3, 12].
In the avian and mouse embryo this region shows tran-
sient loss of actin expression. We do not know whether
differences in embryonic origin, mesenchymal versus
neural crest, are related to these phenomena [3, 12, 25].
Differences in differentiation between the SMC of the
ascending and descending aorta were encountered in this
study with the cytokeratins, and in a previous study [35]
with EDA and EDB splice variants of fibronectin, all
markers of early SMC differentiation. Since the SMC of
the ascending and descending aorta show various differ-
ences in phenotype, varying results can be expected in
studies using aortic tissue from different origins. A dif-
ference in differentiation between SMC of the ascending
and descending aorta was not encountered in studies [20,
35] using SMC contractile proteins, being markers of
late SMC differentiation. These studies showed that the
SMC of both the ascending and descending aorta were
less differentiated than SMC of the DA. The early ap-
pearance of the contactile proteins in the DA may be re-
lated to the intense effective contraction of the SMC
when the DA closes shortly after birth. We could also
show, as reported [1, 16, 36] that the SMC of the DA ex-
press desmin, vimentin [35] and cytokeratin. It is re-
marked in this respect that the DA has a large amount of
hyaluronic acid in both the intima and inner media [8,
30], a correlation that was reported by Kasper and col-
leagues [19].
Cytokeratin re-expression in the DA was observed in
clusters of positive cells at neonatal stages. There was
also an overall variation in cytokeratin expression be-
tween the neonatal DA studied. This variation may have
been due to different stages of maturation and closure of
the DA in the neonate [9]. Our study shows that the clus-
ters of cytokeratin positive cells did not colocalize with
the dedifferentiated areas defined by the absence of cyto-
skeletal and contractile protein differentiation markers
and the presence of EDA: Extra Domain A and EDB:
Extra Domain B fibronectin. These were found in the in-
ner intima and areas of cytolytic necrosis containing apo-
ptotic cells [35]. These apoptotic areas are widely ex-
tended during the anatomical closure of the ductus, but
were not observed in the outer media (unpublished re-
sults). We have no explanation for the special behaviour
of SMC in the outer media, as this area in the DA is
cytokeratin-negative, thus resembling the adjoining elas-
tic vessels. Recent published data [7] show that the outer
media has specific SMC differentiation indicated by the
expression of a retinoic acid responsive SMC phenotype.
The intima and inner media of the DA are actively in-
volved in the process of intimal thickening in the DA
[34] and undergo extensive changes during closure of the
DA [9, 35]. The outer media does not take part in these
processes. Restriction of the location of cytokeratin posi-
tive cells in the neonatal DA may therefore be related to
these phenomena. A direct link with proliferation of
SMC could not be made (unpublished results). Reexpres-
sion of cytokeratins has also been described in patholog-
ic intimal thickening [15, 17, 18]. In fibromuscular le-
sions, particularly those found in vein grafts, cytokera-
tin-positive cells are also found in clusters [18]. The
presence of clusters might relate to a number of phenom-
ena. It is possible that cells in the vessel wall produce a
diffusible factor that is involved in the induction of cyto-
keratin expression [18]. It may also be that these cells
are monoclonal, as was found for large proportions of
the atherosclerotic plaques [2]. Another explanation for
the presence of clusters of cytokeratin-positive cells may
be that these cells are intrinsically unstable in their ex-
pression of genes encoding cytokeratins 8 and 18, as has
been observed for clusters of cytokeratin-positive cells in
transformed non-epithelial cells [21]. Finally, reexpres-
sion of cytokeratins may reflect rearrangement of the
regulation of gene expression [15], as the expression of
cytokeratin 8 and 18 is dependent on the extent of DNA
methylation [27] and requires the coexpression of c-jun
and c-fos proto-oncogene transcription factors [28].
The latter explanation may be the most suitable for
the situation in the neonatal ductus, as this vessel is un-
dergoing many changes particularly in the intima and in-
ner media where the cytokeratin clusters are found dur-
ing postnatal closure [5, 6].
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